powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1942697297
Matthew Mcadams
Neurology
Burlington,
MA
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
505
Beneficiaries
—
Total drug cost
$2.8M
Distinct drugs
10
Brand share
56.2%
Top prescribed drugs
Ofatumumab
256 claims
Baclofen
80 claims
Duloxetine Hcl
40 claims
Gabapentin
28 claims
Modafinil
19 claims
QUALITY · MIPS · 2024
Final MIPS score
92.0
Quality
76.6
Cost
0.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.71%
APM Entity
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.
